# Association of PTPRD/PTPRT Mutation With Better Clinical Outcomes in NSCLC Patients Treated With Immune Checkpoint Blockades

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/association-of-ptprd-ptprt-mutation-with-better-clinical-outcomes-in-nsclc/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Xiaoyan Wang,Bingchen Wu,Zhengqing Yan,Guoqiang Wang,Shiqing Chen,Jian Zeng,Tao Feng,Bichun Xu,Honggang Ke,Mei Li |
| Citations | 53 |
| DOI | 10.3389/fonc.2021.650122 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://doi.org/10.3389/fonc.2021.650122 |
| OpenAlex ID | https://openalex.org/W3169137713 |
| PMID | 34123798 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Mei Li](https://scholariq.org/researchers/mei-li-2/)

## Paper journal

- [Frontiers in Oncology](https://scholariq.org/journals/frontiers-in-oncology/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Protein Tyrosine Phosphatases](https://scholariq.org/topics/protein-tyrosine-phosphatases/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.